Myelodysplastic syndromes with nephrotic syndrome

American Journal of Hematology

Volumn 60, Issue 3, 1999, Pages 200-204

  Saitoh, Takayuki ^a   Murakami, Hirokazu ^b   Uchiumi, Hideki ^a   Moridaira, Kazuaki ^a   Maehara, Tadashi ^a   Matsushima, Takafumi ^a   Tsukamoto, Norifumi ^a   Tamura, Jun'ichi ^a   Karasawa, Masamitsu ^a   Naruse, Takuji ^a   Tsuchiya, Jun ^b  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Nephrotic syndrome; Tumor necrosis factor alpha

Indexed keywords

ETOPOSIDE; HYDROXYUREA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SYNDROME DELINEATION;

AGED; AUTOIMMUNITY; BLOOD CELL COUNT; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEPHROTIC SYNDROME;

EID: 0032974782     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199903)60:3<200::AID-AJH6>3.0.CO;2-0     Document Type: Article

References (30)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAJ, Gralnick HR, Sultan C, the French-American-British (FAB) Co-operative Group. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
2. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483-489.
3. Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes -clinical and cytogenetic features. Eur J Haematol 1995;55:42-48.
4. Baumann MA, Wilson TJ, Patrick CW, Libnoch JA, Keller RH. Immunoregulatory abnormalities in myelodysplastic disorders. Am J Hematol 1986;22:17-26.
5. Jaeger U, Pander S, Bartram C, Haas O, Volc Platzer B, Graninger W, Geissler K, Radaszkiewics T, Lechner K. Autoimmune-thrombocytopenia and SLE in a patient with 5q-anomaly and deletion of the c-fms oncogene. Am J Hematol 1994;45:79-80.
6. Matsushimu T, Murakami H, Kim K. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1p:7q) chromosomal abnormality. Am J Hematol 1995;50:110-115.
7. Koyama A, Fujisaki M, Kobayashi M. A glomerular permeability factor produced by human T cell hybridoma. Kidney Int 1991;40:453-460.
8. Lagrue G, Xhemermont S, Braellec A, Hirbee G, Weil B. A vascular permeability factor produced by Con A-stimulated human lymphocytes. J Immunol 1977;119:1230-1234.
9. Shapiro CM, Vander Laan-BF, Jao W, Sloan DE. Nephrotic syndrome in two patients with cured Hodgkin's disease. Cancer 1985;55:1799-1804.
10. Cronin C, Carmody E, Ryan F, Carmody M. Acute renal failure and non-Hodgkin's lymphonia in a patient with minimal change glomerulonephritis. J Intern Med 1990;228:65-68.
11. Eagan JW. Glomerulopathies of neoplasia. Kidney Int 1997;1:297-306.
12. Keur I. Glomerulopathy as a paraneoplastic phenomenon. Ncth J Med 1989;34:270-284.
13. Mc'Ligeyo SO, Notghi A, Thomson D, Anderton JL. Nephrotic syndrome associated with chronic lymphocytic leukaemia. Nephrol Dial Transplant 1993;8:461-463.
14. Polliack A, Lugassy G. Autoimniunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 1992;4:152-154.
15. Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F, Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 1992;42:127-135.
16. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 1986;63:143-147.
17. Schrier RW, Gottschalk CW. Disease of the kidney. 5th ed. 1993. p 1731-1789.
18. Burstein DM, Korbet SM, Schwurtz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis 1993;22:5-10.
19. Alpers CE. Neoplasia and glomerular injury. Kidney Int 1986;30:465.
20. Eagan JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
21. Sherman RL, Susin M, Weksler ME, Becker EL. Lipoid nephrosis in Hodgkin's disease. Am J Med 1972;52:699-706.
22. Cronin C, Carmody F, Ryan F, Carmody F. Acute renal failure and non-Hodgkin's lymphoma in a patient with minimal change glomerulonephritis. J Int Med 1990;228:65-68.
23. Magli AB, Cohen AH. Monocytes and focal glomerulosclerosis. Lab Invest 1989;61:404-409.
24. Vilafranca M, Ferrer L, Wohlsein P, Trautwein G. Participation of monocytes and macrophages in canine glomerular disease. Zentralbl Veterinarmed A 1994;41:770-779.
25. Osserman EF, Lawlor DP. Serum and urinary lysozyme (muramidase) in monocyte and myelomonocytic leukemia. J Exp Med 1966;128: 921-926.
26. Pruzanki W, Platts ME. Serum and urinary proteins lysozyme and renal dysfunction in mono and myelomonocytic leukemia. J Clin Invest 1970;49:1694-1708.
27. Morschhauser F, Wattel E, Pagniez D, Lovi V, Rose C, Bauters F, Fenaux P. Glomerular injury in chronic myelomonocytic leukemia. Leuk Lymphoma 1995;18:479-483.
28. Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J. Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994;24:799-805.
29. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993;22:622-625.
30. Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 1992;6:1268-1272.